Frank X Leonard insider trades: NovoCure (NVCR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Frank reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | NVCR | ↓ Sell | 5,607 | $13.31 | $75K | Direct | Mar 5, 2026 (1d) |
| Jun 2, 2025 | NVCR | ↓ Sell10b5-1 | 30,196 | $17.50 | $528K | Direct | Jun 4, 2025 (2d) |
| Mar 3, 2025 | NVCR | ↓ Sell | 2,527 | $18.54 | $47K | Direct | Mar 4, 2025 (1d) |
| Feb 28, 2025 | NVCR | ↓ Sell | 15,036 | $19.70 | $296K | Direct | Mar 3, 2025 (3d) |
| Nov 1, 2024 | NVCR | ↓ Sell | 598 | $15.94 | $10K | Direct | Nov 4, 2024 (3d) |
| Mar 4, 2024 | NVCR | ↓ Sell | 2,519 | $16.02 | $40K | Direct | Mar 5, 2024 (1d) |
| Feb 28, 2024 | NVCR | ↓ Sell | 2,078 | $16.14 | $34K | Direct | Feb 29, 2024 (1d) |
| Mar 7, 2023 | NVCR | ↓ Sell10b5-1 | 13,609 | $75.55 | $1.0M | Direct | Mar 7, 2023 (0d) |
| Mar 3, 2023 | NVCR | ↓ Sell | 2,903 | $76.95 | $223K | Direct | Mar 6, 2023 (3d) |
| Mar 2, 2023 | NVCR | ↓ Sell10b5-1 | 4,107 | $75.38 | $310K | Direct | Mar 3, 2023 (1d) |
| Mar 1, 2023 | NVCR | ↓ Sell | 1,684 | $76.36 | $129K | Direct | Mar 2, 2023 (1d) |
| Jan 5, 2023 | NVCR | ↓ Sell10b5-1 | 39,507 | $112.25 | $4.4M | Direct | Jan 9, 2023 (4d) |
| Oct 13, 2022 | NVCR | ↓ Sell | 6,754 | $76.01 | $513K | Direct | Oct 17, 2022 (4d) |
| Oct 6, 2022 | NVCR | ↓ Sell | 6,754 | $84.37 | $570K | Direct | Oct 7, 2022 (1d) |
| Sep 29, 2022 | NVCR | ↓ Sell | 6,754 | $77.35 | $522K | Direct | Sep 30, 2022 (1d) |
| Sep 22, 2022 | NVCR | ↓ Sell | 6,754 | $77.00 | $520K | Direct | Sep 26, 2022 (4d) |
| Sep 15, 2022 | NVCR | ↓ Sell | 12,271 | $88.52 | $1.1M | Direct | Sep 19, 2022 (4d) |
| Sep 9, 2022 | NVCR | ↓ Sell | 1,863 | $88.00 | $164K | Direct | Sep 12, 2022 (3d) |
| Sep 6, 2022 | NVCR | ↓ Sell | 1,384 | $78.57 | $109K | Direct | Sep 7, 2022 (1d) |
| Sep 2, 2022 | NVCR | ↓ Sell | 14,796 | $77.50 | $1.1M | Direct | Sep 6, 2022 (4d) |
| Aug 2, 2022 | NVCR | ↓ Sell | 414 | $69.66 | $29K | Direct | Aug 3, 2022 (1d) |
| Mar 8, 2022 | NVCR | ↓ Sell | 744 | $70.10 | $52K | Direct | Mar 9, 2022 (1d) |
| Mar 4, 2022 | NVCR | ↓ Sell | 1,485 | $72.97 | $108K | Direct | Mar 7, 2022 (3d) |
| Sep 2, 2021 | NVCR | ↓ Sell | 540 | $138.23 | $75K | Direct | Sep 7, 2021 (5d) |
| Aug 3, 2021 | NVCR | ↓ Sell | 1,041 | $149.39 | $156K | Direct | Aug 4, 2021 (1d) |
| Mar 8, 2021 | NVCR | ↓ Sell | 765 | $130.81 | $100K | Direct | Mar 10, 2021 (2d) |
| Mar 4, 2021 | NVCR | ↓ Sell | 567 | $137.55 | $78K | Direct | Mar 8, 2021 (4d) |
| Mar 2, 2021 | NVCR | ↓ Sell | 430 | $152.05 | $65K | Direct | Mar 4, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCR insiders
Open-market trades in the last 12 months
About Frank X Leonard's insider trades
Frank X Leonard is Chief Executive Officer at NovoCure (NVCR). Since Mar 2, 2021, Frank has reported no open-market purchases and 28 sales worth $12.4M on SEC Form 4. In the last 12 months: 1 sale ($75K).
4 sales (51% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (15 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.